Captor Capital Announces Cease Trade Order Related to Delayed Filing of Financial Statements for the Year Ended March 31, 2019

TORONTO, Aug. 07, 2019 (GLOBE NEWSWIRE) — Captor Capital Corp. (CSE: CPTR; FRANKFURT: NMV; STUTTGART: NMVA; USOTC: CPTRF), (“Captor” or the “Company”), a cannabis-focused investment company, announced that a failure-to-file cease trade order has been issued by the securities regulators as of August 6, 2019 as a result of the previously announced delay in filing the Company’s annual audited financial…

Read More

Captor Capital Appoints Dene Rogers as CEO of Captor Acquisition Corp.

TORONTO, Aug. 06, 2019 (GLOBE NEWSWIRE) — Captor Capital Corp. (CSE: CPTR; FRANKFURT: NMV; STUTTGART: NMVA; USOTC: CPTRF), (“Captor” or the “Company”), a cannabis-focused investment company, is pleased to announce the appointment of highly experienced and successful business leader, Dene Rogers, as the CEO of Captor Acquisition Corp.. Captor Acquisition Corp. is a wholly owned subsidiary, under which Captor Capital…

Read More

Captor Capital to Delay Filing of Financial Statements for the Year Ended March 31, 2019

TORONTO, July 29, 2019 (GLOBE NEWSWIRE) — Captor Capital Corp. (CSE: CPTR) (OTCQX:CPTRF) (“Captor” or the “Company”) reports that it expects to be late in filing its audited financial statements and management’s discussion and analysis for the year ended March 31, 2019 (the “Annual Financial Filings”). Although the Company’s audit is progressing to completion, the Company’s auditors are still reviewing…

Read More

Cannabis Biotech Startup, Demetrix Raises $50 Million Series A

Demetrix is engaged as an Emeryville, CA-based biotechnology startup that is focused on the production of cannabinoids. Utilizing microorganisms like baker’s yeast and fermentation, along with advanced biotechnology procedures, Demetrix is able to produce complex ingredients at a very high purity without the excessive costs. The goal is to develop high-quality cannabinoids for the use in pharmaceuticals, supplements, consumer products,…

Read More

10 Cannabis ETFs to Play the Marijuana Boom

Cannabis stocks have had a great start through the first five months of 2019. As we enter the first full year of Canada’s recreational cannabis legalization and prepare for the “second wave” this October, investors have seen overall strong returns despite the early supply issues. In the U.S., more states continue to warm up to the idea of loosening cannabis…

Read More

Captor Capital Announces Availability of Updated Investor Presentation

Captor Capital Corp

TORONTO, May 14, 2019 (GLOBE NEWSWIRE) — Captor Capital Corp. (CSE: CPTR; USOTC: CPTRF; FRANKFURT: NMV; STUTTGART: NMVA;), (“Captor” or the “Company”), a vertically integrated cannabis investment company, is pleased to announce that a new investor presentation will be available on the Company website as of 9:00 a.m. today, May 14. The updated presentation is being released in conjunction with…

Read More

Why the U.S. Market Stands to Be a Massive Catalyst for Cannabis Stocks

In December, the United States Congress agreed to pass into motion the Agriculture Improvement Act of 2018, otherwise known as “The Farm Bill.” Among other initiatives, the Farm Bill reintroduced legislation to legalize commercial hemp production for the first time since 1937. And while Cannabidiol or CBD, currently remains a Schedule 1 drug, the new Farm bill does open the…

Read More

Captor Capital Enters Into Letter of Intent to Acquire Majority Ownership in Michigan Cannabis Opportunity

captor capital

April 09, 2019 07:59 ET | Source: Captor Capital Corp. 20 retail cannabis licenses Two processing licenses Eight cultivation licenses TORONTO, April 09, 2019 (GLOBE NEWSWIRE) — Captor Capital Corp. (CSE: CPTR; USOTC: CPTRF; FRANKFURT: NMV; STUTTGART: NMVA), (“Captor” or the “Company”), a vertically integrated investment company focused on cannabis, is pleased to announce that it has entered into a…

Read More

Captor Capital Announces Letter of Intent to Acquire Premiere THC Manufacturing Facility from People’s Holdings

Captor Capital Corp

TORONTO, March 29, 2019 (GLOBE NEWSWIRE) — Captor Capital Corp. (CSE: CPTR; FRANKFURT: NMV; STUTTGART: NMVA; USOTC: CPTRF), (“Captor” or the “Company”), a vertically integrated cannabis-focused investment company, is pleased to announce that a wholly owned subsidiary of the Company has entered into a Letter of Intent (“LOI”) to acquire 100 per cent ownership of a Type 7 Volatile Solvent…

Read More

Captor Capital Announces Commencement of Trading on OTCQX® Best Market

Captor Capital

TORONTO, March 18, 2019 (GLOBE NEWSWIRE) — Captor Capital Corp. (“Captor” or the “Company”) (CSE: CPTR; FRANKFURT: NMV; STUTTGART: NMVA; OTCQX: CPTRF), a cannabis-focused investment company, is pleased to announce it has qualified for trading on the OTCQX® Best Market (“OTCQX”). Captor Capital upgraded to OTCQX from the Pink® market. The OTCQX Market is reserved for established, investor-focused U.S. and…

Read More